ArticleJournal for immunotherapy of cancer2019

PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity.

Jianshu Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.